Could a blood test predict whether coronavirus will kill you? Researchers find five signs for inflammation and blood vessel problems that could tell doctors which coronavirus patients are at risk for fatal infection

Researchers at George Washington University (GWU) believe that a simple blood test could predict which coronavirus patients could become deathly ill.

The scientists have identified five biomarkers that indicate risks of complications like inflammation and bleeding disorders that make someone more likely to die if they contract coronavirus.

High levels of two of these blood indicators, in particular, are linked to far greater odds of dying from the infection.

The GWU team believes a blood test for these biomarkers could give doctors a clearer picture of who might need ventilator support or early aggressive treatment with a more finely tuned tool than general risk factors like age and underlying conditions.

People over the age of 65 and those with underlying conditions are typically less able to fight off any infection, not just COVID-19.

But coronavirus has proven deadly to scores of otherwise healthy, relatively young people too – and scientists are still not sure exactly why some COVID-19 patients quickly spiral downward and others have no symptoms at all.

And knowing who might need the most aggressive care is critical for hospitals when the threat of drug and supply shortages looms.

New York City narrowly avoided a shortage of ventilators when it became the global epicenter of the pandemic in March and April.

Several hospitals in hard-hit parts of Texas completely ran out of beds for coronavirus patients (or others) as cases spiked there in June and July.

Even though Texas and other sunbelt states are seeing fewer new cases per day, hospitalization rates remain high. Florida reported a new record high number of coronavirus deaths in a single day on Tuesday and cases continue to climb in states like Georgia, Alabama, Illinois and Illinois.

And nationwide, there are still shortages of drugs needed for patients on mechanical ventilators and of the only FDA-authorized treatment, remdesivir.

Treating any and all patients sick enough to need to be hospitalized as early as possible is the best course of action – but it’s also a luxury doctors may not have the needed supplies are so precious.

Grim though it may sound, health care providers may have to choose for one patient to get treatment over another – and a blood test could make these decisions both easier and more likely to be the correct ones.

Click here to read more.
Source: Daily Mail